Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110.60 EUR | -0.85% |
|
-1.95% | -20.94% |
07-18 | Merck KGaA Gets Conditional Approval To Market Ezmekly Drug in EU | DJ |
07-18 | Merck KGaA Gets EU Conditional Marketing Approval for Plexiform Neurofibroma Therapy | MT |
Main competitors
Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
2.11% | 2.2% | 15.52x | 1.5x | 2.51x | 8.85x | 13.33x | 56.04B | ||
2.39% | 2.46% | 23.75x | 1.51x | 2.28x | 10.44x | 14.08x | 8.9B | ||
0.37% | 0.37% | 85x | 4.72x | 4.32x | 53.1x | 86.31x | 7.1B | ||
-.--% | 0.05% | 60.15x | 11.94x | 10.99x | 43.9x | 48.21x | 5.81B | ||
0.57% | 0.73% | 37.25x | 4.28x | 7.64x | 19.19x | 37.82x | 3.69B | ||
2.05% | 2.31% | 12.14x | 1.1x | - | - | - | 2.04B | ||
-.--% | -.--% | 14.07x | -61.95x | 1.9x | 7.53x | 8.52x | 2.01B | ||
0.85% | - | 15.32x | 2.1x | - | - | - | 1.29B | ||
2.68% | 2.8% | 14.58x | 0.85x | - | - | - | 1.18B | ||
Average | 1.22% | 1.36% | 30.87x | -3.77x | 4.94x | 23.83x | 34.71x | 9.78B | |
Weighted average by Cap. | 1.73% | 1.83% | 25.68x | 1.11x | 3.44x | 15.64x | 23.00x |
- Stock Market
- Equities
- MRK Stock
- Sector Merck KGaA
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition